Betekenis van:
genome

Voorbeeldzinnen

1. European Best Practice in Genome-based Information and Technologies
2. High-throughput research: to catalyse progress in fundamental genomics (genome and post-genome) and biomedical research by enhancing data generation, standardisation, acquisition and analysis.
3. studies on genome-based diagnostic applications and drug development (e.g. pharmacogenomics),
4. The sequencing of the human genome and the recent advances in post-genomics have revolutionised research into human health and diseases.
5. two consecutive tests at seven days interval for the detection of the classical swine fever virus genome (RT-PCR) carried out in the national reference laboratory.
6. In case of quantitative methods, the limit of quantification (LOQ) is the lowest level of analyte that can be reliable quantified, given a known number of target taxon genome copies.
7. In case of qualitative methods, the limit of detection (LOD) is the lowest level of analyte that can be reliably detected, given a known number of target taxon genome copies.
8. The Ice Structuring Protein (ISP) preparation is a light-brown liquid produced by submerged fermentation of a genetically-modified strain of food-grade baker’s yeast (Saccharomyces cerevisiae) in which a synthetic gene for the ISP has been inserted into the yeast’s genome.
9. Member States shall ensure that avian influenza viruses, their genome and antigens, and vaccines for research, diagnosis or manufacture of vaccine shall be manipulated or used only in places, establishments or laboratories approved by the competent authority where the appropriate biosecurity requirements are guaranteed.
10. To produce the first edition of ‘European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies’ using an interdisciplinary approach by, e.g., Public Health experts, EU lawyers, Human Geneticists and patient groups reviewing the available evidence including evidence emerging from relevant European research and health action networks.
11. or [they have been isolated for at least 10 days prior to export and have been subjected to a test for the detection of H5N1antigen or genome, as prescribed in Chapter 2.1.14 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, carried out on a sample taken not earlier than on the third day of isolation] (1)
12. or [they have been isolated for at least 10 days prior to export and have been subjected to a test for the detection of H5N1 antigen or genome, as prescribed in Chapter 2.1.14 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, carried out on a sample taken not earlier than on the third day of isolation] (1)
13. have been in isolation for at least 10 days prior to export and have undergone a test to detect the H5N1 antigen or genome as laid down in Chapter 2.7.12 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals carried out on a sample taken not earlier than the third day of isolation.
14. Type A viruses of the subtypes H5 or H7 with genome sequences codified for multiple basic amino acids at the cleavage site of the haemagglutinin molecule similar to that observed for other HPAI viruses, indicating that the haemagglutinin molecule can be cleaved by a host ubiquitous protease;
15. have been in isolation for at least 10 days prior to export and have undergone a test to detect the H5N1 antigen or genome as laid down in Chapter 2.1.14 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals carried out on a sample taken not earlier than the third day of isolation.